Amphion builds shareholder value in high growth companies in the medical and technology sectors by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.
Amphion has a significant shareholding in 8 partner companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each partner company is chosen with the goal of achieving an exit valuation in excess of $100 million.
Location: United Kingdom, England